APO Research
Talk to an analyst

APO RESEARCH · REPORT

Health and Medical Microalgae

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Health and Medical Microalgae Market Outlook and Growth Opportunities 2026

5 March 2026191 pages

Choose your research edition.

Industry ResearchHealth and Medical Microalgae Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Health and Medical Microalgae Industry Growth and Trends Forecast to 2032105 pages · $3,450 USDMarket StructureGlobal Health and Medical Microalgae Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Health and Medical Microalgae Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Health and Medical Microalgae Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Health and Medical Microalgae market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Health and Medical Microalgae is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Health and Medical Microalgae is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Health and Medical Microalgae is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Health and Medical Microalgae market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Health and Medical Microalgae market include DIC Corporation, Koninkliijke DSM NV, Roquette Frères, Sun chlorella, Cellana LLC, Fuji Chemical Industries Co., Ltd., Yunnan Green-A-Bio-engineering Co Ltd, Cyanotech Corporation and BASF SE, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Health and Medical Microalgae market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Health and Medical Microalgae and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Health and Medical Microalgae sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Health and Medical Microalgae market size, projected growth trends, production technologies, key applications, and end-use industries.

Health and Medical Microalgae Segment by Company

DIC Corporation

Koninkliijke DSM NV

Roquette Frères

Sun chlorella

Cellana LLC

Fuji Chemical Industries Co., Ltd.

Yunnan Green-A-Bio-engineering Co Ltd

Cyanotech Corporation

BASF SE

Parry Nutraceuticals

Beijing Gingko Group

Health and Medical Microalgae Segment by Type

Spirulina

Chlorella

Dunaliella

Aphanizomenon

Haematococcus

Crypthecodinium

Schizochytrium

Euglena

Nannochloropsis

Others

Health and Medical Microalgae Segment by Application

Nutraceuticals and Dietary Supplements

Pharmaceuticals

Health and Medical Microalgae Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Health and Medical Microalgae status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Health and Medical Microalgae market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Health and Medical Microalgae significant trends, drivers, influence factors in global and regions.

6. To analyze Health and Medical Microalgae competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Health and Medical Microalgae market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Health and Medical Microalgae and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Health and Medical Microalgae.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Health and Medical Microalgae market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Health and Medical Microalgae industry.

Chapter 3: Detailed analysis of Health and Medical Microalgae manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Health and Medical Microalgae in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Health and Medical Microalgae in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Health and Medical Microalgae Industry Trends Table 2. Health and Medical Microalgae Industry Drivers Table 3. Health and Medical Microalgae Industry Opportunities and Challenges Table 4. Health and Medical Microalgae Industry Restraints Table 5. Global Health and Medical Microalgae Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Health and Medical Microalgae Revenue Share by Company (2021-2026) Table 7. Global Health and Medical Microalgae Sales Volume by Company (t) & (2021-2026) Table 8. Global Health and Medical Microalgae Sales Volume Share by Company (2021-2026) Table 9. Global Health and Medical Microalgae Average Price (USD/t) of Company (2021-2026) Table 10. Global Health and Medical Microalgae Company Ranking, (2024-2026) & (USD Million) Table 11. Global Health and Medical Microalgae Key Company Manufacturing Base & Headquarters Table 12. Global Health and Medical Microalgae Company, Product Type & Application Table 13. Global Health and Medical Microalgae Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Health and Medical Microalgae by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Spirulina Table 18. Significant Companies of Chlorella Table 19. Significant Companies of Dunaliella Table 20. Significant Companies of Aphanizomenon Table 21. Significant Companies of Haematococcus Table 22. Significant Companies of Crypthecodinium Table 23. Significant Companies of Schizochytrium Table 24. Significant Companies of Euglena Table 25. Significant Companies of Nannochloropsis Table 26. Significant Companies of Others Table 27. Global Health and Medical Microalgae Sales Volume by Type 2021 VS 2025 VS 2032 (t) Table 28. Global Health and Medical Microalgae Sales Volume by Type (2021-2026) & (t) Table 29. Global Health and Medical Microalgae Sales Volume by Type (2027-2032) & (t) Table 30. Global Health and Medical Microalgae Sales Volume Share by Type (2021-2026) Table 31. Global Health and Medical Microalgae Sales Volume Share by Type (2027-2032) Table 32. Global Health and Medical Microalgae Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Health and Medical Microalgae Sales Value by Type (2021-2026) & (US$ Million) Table 34. Global Health and Medical Microalgae Sales Value by Type (2027-2032) & (US$ Million) Table 35. Global Health and Medical Microalgae Sales Value Share by Type (2021-2026) Table 36. Global Health and Medical Microalgae Sales Value Share by Type (2027-2032) Table 37. Significant Companies of Nutraceuticals and Dietary Supplements Table 38. Significant Companies of Pharmaceuticals Table 39. Global Health and Medical Microalgae Sales Volume by Application 2021 VS 2025 VS 2032 (t) Table 40. Global Health and Medical Microalgae Sales Volume by Application (2021-2026) & (t) Table 41. Global Health and Medical Microalgae Sales Volume by Application (2027-2032) & (t) Table 42. Global Health and Medical Microalgae Sales Volume Share by Application (2021-2026) Table 43. Global Health and Medical Microalgae Sales Volume Share by Application (2027-2032) Table 44. Global Health and Medical Microalgae Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 45. Global Health and Medical Microalgae Sales Value by Application (2021-2026) & (US$ Million) Table 46. Global Health and Medical Microalgae Sales Value by Application (2027-2032) & (US$ Million) Table 47. Global Health and Medical Microalgae Sales Value Share by Application (2021-2026) Table 48. Global Health and Medical Microalgae Sales Value Share by Application (2027-2032) Table 49. Global Health and Medical Microalgae Sales by Region: 2021 VS 2025 VS 2032 (t) Table 50. Global Health and Medical Microalgae Sales by Region (2021-2026) & (t) Table 51. Global Health and Medical Microalgae Sales Market Share by Region (2021-2026) Table 52. Global Health and Medical Microalgae Sales by Region (2027-2032) & (t) Table 53. Global Health and Medical Microalgae Sales Market Share by Region (2027-2032) Table 54. Global Health and Medical Microalgae Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 55. Global Health and Medical Microalgae Sales Value by Region (2021-2026) & (US$ Million) Table 56. Global Health and Medical Microalgae Sales Value Share by Region (2021-2026) Table 57. Global Health and Medical Microalgae Sales Value by Region (2027-2032) & (US$ Million) Table 58. Global Health and Medical Microalgae Sales Value Share by Region (2027-2032) Table 59. Global Health and Medical Microalgae Market Average Price (USD/t) by Region (2021-2026) Table 60. Global Health and Medical Microalgae Market Average Price (USD/t) by Region (2027-2032) Table 61. Global Health and Medical Microalgae Sales by Country: 2021 VS 2025 VS 2032 (t) Table 62. Global Health and Medical Microalgae Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 63. Global Health and Medical Microalgae Sales by Country (2021-2026) & (t) Table 64. Global Health and Medical Microalgae Sales Market Share by Country (2021-2026) Table 65. Global Health and Medical Microalgae Sales by Country (2027-2032) & (t) Table 66. Global Health and Medical Microalgae Sales Market Share by Country (2027-2032) Table 67. Global Health and Medical Microalgae Sales Value by Country (2021-2026) & (US$ Million) Table 68. Global Health and Medical Microalgae Sales Value Market Share by Country (2021-2026) Table 69. Global Health and Medical Microalgae Sales Value by Country (2027-2032) & (US$ Million) Table 70. Global Health and Medical Microalgae Sales Value Market Share by Country (2027-2032) Table 71. DIC Corporation Company Information Table 72. DIC Corporation Business Overview Table 73. DIC Corporation Health and Medical Microalgae Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 74. DIC Corporation Health and Medical Microalgae Product Portfolio Table 75. DIC Corporation Recent Development Table 76. Koninkliijke DSM NV Company Information Table 77. Koninkliijke DSM NV Business Overview Table 78. Koninkliijke DSM NV Health and Medical Microalgae Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 79. Koninkliijke DSM NV Health and Medical Microalgae Product Portfolio Table 80. Koninkliijke DSM NV Recent Development Table 81. Roquette Frères Company Information Table 82. Roquette Frères Business Overview Table 83. Roquette Frères Health and Medical Microalgae Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 84. Roquette Frères Health and Medical Microalgae Product Portfolio Table 85. Roquette Frères Recent Development Table 86. Sun chlorella Company Information Table 87. Sun chlorella Business Overview Table 88. Sun chlorella Health and Medical Microalgae Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 89. Sun chlorella Health and Medical Microalgae Product Portfolio Table 90. Sun chlorella Recent Development Table 91. Cellana LLC Company Information Table 92. Cellana LLC Business Overview Table 93. Cellana LLC Health and Medical Microalgae Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 94. Cellana LLC Health and Medical Microalgae Product Portfolio Table 95. Cellana LLC Recent Development Table 96. Fuji Chemical Industries Co., Ltd. Company Information Table 97. Fuji Chemical Industries Co., Ltd. Business Overview Table 98. Fuji Chemical Industries Co., Ltd. Health and Medical Microalgae Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 99. Fuji Chemical Industries Co., Ltd. Health and Medical Microalgae Product Portfolio Table 100. Fuji Chemical Industries Co., Ltd. Recent Development Table 101. Yunnan Green-A-Bio-engineering Co Ltd Company Information Table 102. Yunnan Green-A-Bio-engineering Co Ltd Business Overview Table 103. Yunnan Green-A-Bio-engineering Co Ltd Health and Medical Microalgae Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 104. Yunnan Green-A-Bio-engineering Co Ltd Health and Medical Microalgae Product Portfolio Table 105. Yunnan Green-A-Bio-engineering Co Ltd Recent Development Table 106. Cyanotech Corporation Company Information Table 107. Cyanotech Corporation Business Overview Table 108. Cyanotech Corporation Health and Medical Microalgae Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 109. Cyanotech Corporation Health and Medical Microalgae Product Portfolio Table 110. Cyanotech Corporation Recent Development Table 111. BASF SE Company Information Table 112. BASF SE Business Overview Table 113. BASF SE Health and Medical Microalgae Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 114. BASF SE Health and Medical Microalgae Product Portfolio Table 115. BASF SE Recent Development Table 116. Parry Nutraceuticals Company Information Table 117. Parry Nutraceuticals Business Overview Table 118. Parry Nutraceuticals Health and Medical Microalgae Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 119. Parry Nutraceuticals Health and Medical Microalgae Product Portfolio Table 120. Parry Nutraceuticals Recent Development Table 121. Beijing Gingko Group Company Information Table 122. Beijing Gingko Group Business Overview Table 123. Beijing Gingko Group Health and Medical Microalgae Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 124. Beijing Gingko Group Health and Medical Microalgae Product Portfolio Table 125. Beijing Gingko Group Recent Development Table 126. Key Raw Materials Table 127. Raw Materials Key Suppliers Table 128. Health and Medical Microalgae Distributors List Table 129. Health and Medical Microalgae Customers List Table 130. Research Programs/Design for This Report Table 131. Authors List of This Report Table 132. Secondary Sources Table 133. Primary Sources List of Figures Figure 1. Health and Medical Microalgae Product Image Figure 2. Global Health and Medical Microalgae Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Health and Medical Microalgae Sales Value (2021-2032) & (US$ Million) Figure 4. Global Health and Medical Microalgae Sales (2021-2032) & (t) Figure 5. Global Health and Medical Microalgae Sales Average Price (USD/t) & (2021-2032) Figure 6. Global Health and Medical Microalgae Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Spirulina Image Figure 10. Chlorella Image Figure 11. Dunaliella Image Figure 12. Aphanizomenon Image Figure 13. Haematococcus Image Figure 14. Crypthecodinium Image Figure 15. Schizochytrium Image Figure 16. Euglena Image Figure 17. Nannochloropsis Image Figure 18. Others Image Figure 19. Global Health and Medical Microalgae Sales Volume by Type (2021 VS 2025 VS 2032) & (t) Figure 20. Global Health and Medical Microalgae Sales Volume Share 2021 VS 2025 VS 2032 Figure 21. Global Health and Medical Microalgae Sales Volume Share by Type (2021-2032) Figure 22. Global Health and Medical Microalgae Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Health and Medical Microalgae Sales Value Share 2021 VS 2025 VS 2032 Figure 24. Global Health and Medical Microalgae Sales Value Share by Type (2021-2032) Figure 25. Nutraceuticals and Dietary Supplements Image Figure 26. Pharmaceuticals Image Figure 27. Global Health and Medical Microalgae Sales Volume by Application (2021 VS 2025 VS 2032) & (t) Figure 28. Global Health and Medical Microalgae Sales Volume Share 2021 VS 2025 VS 2032 Figure 29. Global Health and Medical Microalgae Sales Volume Share by Application (2021-2032) Figure 30. Global Health and Medical Microalgae Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 31. Global Health and Medical Microalgae Sales Value Share 2021 VS 2025 VS 2032 Figure 32. Global Health and Medical Microalgae Sales Value Share by Application (2021-2032) Figure 33. Global Health and Medical Microalgae Sales by Region: 2021 VS 2025 VS 2032 (t) Figure 34. Global Health and Medical Microalgae Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 35. Global Health and Medical Microalgae Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 36. Global Health and Medical Microalgae Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 37. North America Health and Medical Microalgae Sales Value (2021-2032) & (US$ Million) Figure 38. North America Health and Medical Microalgae Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Europe Health and Medical Microalgae Sales Value (2021-2032) & (US$ Million) Figure 40. Europe Health and Medical Microalgae Sales Value Share by Country (%), 2025 VS 2032 Figure 41. Asia-Pacific Health and Medical Microalgae Sales Value (2021-2032) & (US$ Million) Figure 42. Asia-Pacific Health and Medical Microalgae Sales Value Share by Country (%), 2025 VS 2032 Figure 43. South America Health and Medical Microalgae Sales Value (2021-2032) & (US$ Million) Figure 44. South America Health and Medical Microalgae Sales Value Share by Country (%), 2025 VS 2032 Figure 45. Middle East & Africa Health and Medical Microalgae Sales Value (2021-2032) & (US$ Million) Figure 46. Middle East & Africa Health and Medical Microalgae Sales Value Share by Country (%), 2025 VS 2032 Figure 47. USA Health and Medical Microalgae Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. USA Health and Medical Microalgae Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. USA Health and Medical Microalgae Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Canada Health and Medical Microalgae Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Canada Health and Medical Microalgae Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Canada Health and Medical Microalgae Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Mexico Health and Medical Microalgae Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Mexico Health and Medical Microalgae Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Mexico Health and Medical Microalgae Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. Germany Health and Medical Microalgae Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. Germany Health and Medical Microalgae Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. Germany Health and Medical Microalgae Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. France Health and Medical Microalgae Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. France Health and Medical Microalgae Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. France Health and Medical Microalgae Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. U.K. Health and Medical Microalgae Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. U.K. Health and Medical Microalgae Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. U.K. Health and Medical Microalgae Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Italy Health and Medical Microalgae Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Italy Health and Medical Microalgae Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Italy Health and Medical Microalgae Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Spain Health and Medical Microalgae Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Spain Health and Medical Microalgae Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Spain Health and Medical Microalgae Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Russia Health and Medical Microalgae Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Russia Health and Medical Microalgae Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Russia Health and Medical Microalgae Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. Netherlands Health and Medical Microalgae Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. Netherlands Health and Medical Microalgae Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. Netherlands Health and Medical Microalgae Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Nordic Countries Health and Medical Microalgae Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Nordic Countries Health and Medical Microalgae Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Nordic Countries Health and Medical Microalgae Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. China Health and Medical Microalgae Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. China Health and Medical Microalgae Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. China Health and Medical Microalgae Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. Japan Health and Medical Microalgae Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. Japan Health and Medical Microalgae Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. Japan Health and Medical Microalgae Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. South Korea Health and Medical Microalgae Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. South Korea Health and Medical Microalgae Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. South Korea Health and Medical Microalgae Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. India Health and Medical Microalgae Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. India Health and Medical Microalgae Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. India Health and Medical Microalgae Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Australia Health and Medical Microalgae Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Australia Health and Medical Microalgae Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Australia Health and Medical Microalgae Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Southeast Asia Health and Medical Microalgae Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Southeast Asia Health and Medical Microalgae Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Southeast Asia Health and Medical Microalgae Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Brazil Health and Medical Microalgae Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Brazil Health and Medical Microalgae Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Brazil Health and Medical Microalgae Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Argentina Health and Medical Microalgae Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Argentina Health and Medical Microalgae Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Argentina Health and Medical Microalgae Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Chile Health and Medical Microalgae Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Chile Health and Medical Microalgae Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Chile Health and Medical Microalgae Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Colombia Health and Medical Microalgae Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Colombia Health and Medical Microalgae Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Colombia Health and Medical Microalgae Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Peru Health and Medical Microalgae Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Peru Health and Medical Microalgae Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Peru Health and Medical Microalgae Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Saudi Arabia Health and Medical Microalgae Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. Saudi Arabia Health and Medical Microalgae Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. Saudi Arabia Health and Medical Microalgae Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Israel Health and Medical Microalgae Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Israel Arabia Health and Medical Microalgae Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Israel Arabia Health and Medical Microalgae Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. UAE Health and Medical Microalgae Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. UAE Health and Medical Microalgae Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. UAE Health and Medical Microalgae Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Turkey Health and Medical Microalgae Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Turkey Health and Medical Microalgae Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Turkey Health and Medical Microalgae Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Iran Health and Medical Microalgae Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 126. Iran Health and Medical Microalgae Sales Value Share by Type, 2025 VS 2032 & (%) Figure 127. Iran Health and Medical Microalgae Sales Value Share by Application, 2025 VS 2032 & (%) Figure 128. Egypt Health and Medical Microalgae Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 129. Egypt Health and Medical Microalgae Sales Value Share by Type, 2025 VS 2032 & (%) Figure 130. Egypt Health and Medical Microalgae Sales Value Share by Application, 2025 VS 2032 & (%) Figure 131. Health and Medical Microalgae Value Chain Figure 132. Manufacturing Cost Structure Figure 133. Health and Medical Microalgae Sales Mode & Process Figure 134. Direct Comparison with Distribution Share Figure 135. Distributors Profiles Figure 136. Years Considered Figure 137. Research Process Figure 138. Key Executives Interviewed

Scope & coverage.

Types
  • Spirulina
  • Chlorella
  • Dunaliella
  • Aphanizomenon
  • Haematococcus
  • Crypthecodinium
  • Schizochytrium
  • Euglena
  • Nannochloropsis
  • Others
Applications
  • Nutraceuticals and Dietary Supplements
  • Pharmaceuticals
Companies covered
  • DIC Corporation
  • Koninkliijke DSM NV
  • Roquette Frères
  • Sun chlorella
  • Cellana LLC
  • Fuji Chemical Industries Co., Ltd.
  • Yunnan Green-A-Bio-engineering Co Ltd
  • Cyanotech Corporation
  • BASF SE
  • Parry Nutraceuticals
  • Beijing Gingko Group

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Health and Medical Microalgae Sales Value (2021-2032)
  4. 1.2.2 Global Health and Medical Microalgae Sales Volume (2021-2032)
  5. 1.2.3 Global Health and Medical Microalgae Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Health and Medical Microalgae Market Dynamics
  1. 2.1 Health and Medical Microalgae Industry Trends
  2. 2.2 Health and Medical Microalgae Industry Drivers
  3. 2.3 Health and Medical Microalgae Industry Opportunities and Challenges
  4. 2.4 Health and Medical Microalgae Industry Restraints
3 Health and Medical Microalgae Market by Company
  1. 3.1 Global Health and Medical Microalgae Company Revenue Ranking in 2025
  2. 3.2 Global Health and Medical Microalgae Revenue by Company (2021-2026)
  3. 3.3 Global Health and Medical Microalgae Sales Volume by Company (2021-2026)
  4. 3.4 Global Health and Medical Microalgae Average Price by Company (2021-2026)
  5. 3.5 Global Health and Medical Microalgae Company Ranking (2024-2026)
  6. 3.6 Global Health and Medical Microalgae Company Manufacturing Base and Headquarters
  7. 3.7 Global Health and Medical Microalgae Company Product Type and Application
  8. 3.8 Global Health and Medical Microalgae Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Health and Medical Microalgae Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Health and Medical Microalgae Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Health and Medical Microalgae Market by Type
  1. 4.1 Health and Medical Microalgae Type Introduction
  2. 4.1.1 Spirulina
  3. 4.1.2 Chlorella
  4. 4.1.3 Dunaliella
  5. 4.1.4 Aphanizomenon
  6. 4.1.5 Haematococcus
  7. 4.1.6 Crypthecodinium
  8. 4.1.7 Schizochytrium
  9. 4.1.8 Euglena
  10. 4.1.9 Nannochloropsis
  11. 4.1.10 Others
  12. 4.2 Global Health and Medical Microalgae Sales Volume by Type
  13. 4.2.1 Global Health and Medical Microalgae Sales Volume by Type (2021 VS 2025 VS 2032)
  14. 4.2.2 Global Health and Medical Microalgae Sales Volume by Type (2021-2032)
  15. 4.2.3 Global Health and Medical Microalgae Sales Volume Share by Type (2021-2032)
  16. 4.3 Global Health and Medical Microalgae Sales Value by Type
  17. 4.3.1 Global Health and Medical Microalgae Sales Value by Type (2021 VS 2025 VS 2032)
  18. 4.3.2 Global Health and Medical Microalgae Sales Value by Type (2021-2032)
  19. 4.3.3 Global Health and Medical Microalgae Sales Value Share by Type (2021-2032)
5 Health and Medical Microalgae Market by Application
  1. 5.1 Health and Medical Microalgae Application Introduction
  2. 5.1.1 Nutraceuticals and Dietary Supplements
  3. 5.1.2 Pharmaceuticals
  4. 5.2 Global Health and Medical Microalgae Sales Volume by Application
  5. 5.2.1 Global Health and Medical Microalgae Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Health and Medical Microalgae Sales Volume by Application (2021-2032)
  7. 5.2.3 Global Health and Medical Microalgae Sales Volume Share by Application (2021-2032)
  8. 5.3 Global Health and Medical Microalgae Sales Value by Application
  9. 5.3.1 Global Health and Medical Microalgae Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Health and Medical Microalgae Sales Value by Application (2021-2032)
  11. 5.3.3 Global Health and Medical Microalgae Sales Value Share by Application (2021-2032)
6 Health and Medical Microalgae Regional Sales and Value Analysis
  1. 6.1 Global Health and Medical Microalgae Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Health and Medical Microalgae Sales by Region (2021-2032)
  3. 6.2.1 Global Health and Medical Microalgae Sales by Region: 2021-2026
  4. 6.2.2 Global Health and Medical Microalgae Sales by Region (2027-2032)
  5. 6.3 Global Health and Medical Microalgae Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Health and Medical Microalgae Sales Value by Region (2021-2032)
  7. 6.4.1 Global Health and Medical Microalgae Sales Value by Region: 2021-2026
  8. 6.4.2 Global Health and Medical Microalgae Sales Value by Region (2027-2032)
  9. 6.5 Global Health and Medical Microalgae Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Health and Medical Microalgae Sales Value (2021-2032)
  12. 6.6.2 North America Health and Medical Microalgae Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Health and Medical Microalgae Sales Value (2021-2032)
  15. 6.7.2 Europe Health and Medical Microalgae Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Health and Medical Microalgae Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Health and Medical Microalgae Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Health and Medical Microalgae Sales Value (2021-2032)
  21. 6.9.2 South America Health and Medical Microalgae Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Health and Medical Microalgae Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Health and Medical Microalgae Sales Value Share by Country, 2025 VS 2032
7 Health and Medical Microalgae Country-level Sales and Value Analysis
  1. 7.1 Global Health and Medical Microalgae Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Health and Medical Microalgae Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Health and Medical Microalgae Sales by Country (2021-2032)
  4. 7.3.1 Global Health and Medical Microalgae Sales by Country (2021-2026)
  5. 7.3.2 Global Health and Medical Microalgae Sales by Country (2027-2032)
  6. 7.4 Global Health and Medical Microalgae Sales Value by Country (2021-2032)
  7. 7.4.1 Global Health and Medical Microalgae Sales Value by Country (2021-2026)
  8. 7.4.2 Global Health and Medical Microalgae Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Health and Medical Microalgae Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Health and Medical Microalgae Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Health and Medical Microalgae Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Health and Medical Microalgae Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Health and Medical Microalgae Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Health and Medical Microalgae Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Health and Medical Microalgae Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Health and Medical Microalgae Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Health and Medical Microalgae Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Health and Medical Microalgae Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Health and Medical Microalgae Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Health and Medical Microalgae Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Health and Medical Microalgae Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Health and Medical Microalgae Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Health and Medical Microalgae Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Health and Medical Microalgae Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Health and Medical Microalgae Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Health and Medical Microalgae Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Health and Medical Microalgae Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Health and Medical Microalgae Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Health and Medical Microalgae Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Health and Medical Microalgae Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Health and Medical Microalgae Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Health and Medical Microalgae Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Health and Medical Microalgae Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Health and Medical Microalgae Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Health and Medical Microalgae Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Health and Medical Microalgae Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Health and Medical Microalgae Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Health and Medical Microalgae Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Health and Medical Microalgae Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Health and Medical Microalgae Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Health and Medical Microalgae Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Health and Medical Microalgae Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Health and Medical Microalgae Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Health and Medical Microalgae Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Health and Medical Microalgae Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Health and Medical Microalgae Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Health and Medical Microalgae Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Health and Medical Microalgae Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Health and Medical Microalgae Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Health and Medical Microalgae Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Health and Medical Microalgae Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Health and Medical Microalgae Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Health and Medical Microalgae Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Health and Medical Microalgae Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Health and Medical Microalgae Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Health and Medical Microalgae Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Health and Medical Microalgae Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Health and Medical Microalgae Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Health and Medical Microalgae Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Health and Medical Microalgae Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Health and Medical Microalgae Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Health and Medical Microalgae Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Health and Medical Microalgae Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Health and Medical Microalgae Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Health and Medical Microalgae Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Health and Medical Microalgae Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Health and Medical Microalgae Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Health and Medical Microalgae Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Health and Medical Microalgae Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Health and Medical Microalgae Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Health and Medical Microalgae Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Health and Medical Microalgae Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Health and Medical Microalgae Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Health and Medical Microalgae Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Health and Medical Microalgae Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Health and Medical Microalgae Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Health and Medical Microalgae Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Health and Medical Microalgae Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Health and Medical Microalgae Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Health and Medical Microalgae Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Health and Medical Microalgae Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Health and Medical Microalgae Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Health and Medical Microalgae Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Health and Medical Microalgae Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Health and Medical Microalgae Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Health and Medical Microalgae Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Health and Medical Microalgae Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Health and Medical Microalgae Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Health and Medical Microalgae Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Health and Medical Microalgae Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Health and Medical Microalgae Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Health and Medical Microalgae Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 DIC Corporation
  2. 8.1.1 DIC Corporation Company Information
  3. 8.1.2 DIC Corporation Business Overview
  4. 8.1.3 DIC Corporation Health and Medical Microalgae Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 DIC Corporation Health and Medical Microalgae Product Portfolio
  6. 8.1.5 DIC Corporation Recent Developments
  7. 8.2 Koninkliijke DSM NV
  8. 8.2.1 Koninkliijke DSM NV Company Information
  9. 8.2.2 Koninkliijke DSM NV Business Overview
  10. 8.2.3 Koninkliijke DSM NV Health and Medical Microalgae Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Koninkliijke DSM NV Health and Medical Microalgae Product Portfolio
  12. 8.2.5 Koninkliijke DSM NV Recent Developments
  13. 8.3 Roquette Frères
  14. 8.3.1 Roquette Frères Company Information
  15. 8.3.2 Roquette Frères Business Overview
  16. 8.3.3 Roquette Frères Health and Medical Microalgae Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Roquette Frères Health and Medical Microalgae Product Portfolio
  18. 8.3.5 Roquette Frères Recent Developments
  19. 8.4 Sun chlorella
  20. 8.4.1 Sun chlorella Company Information
  21. 8.4.2 Sun chlorella Business Overview
  22. 8.4.3 Sun chlorella Health and Medical Microalgae Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Sun chlorella Health and Medical Microalgae Product Portfolio
  24. 8.4.5 Sun chlorella Recent Developments
  25. 8.5 Cellana LLC
  26. 8.5.1 Cellana LLC Company Information
  27. 8.5.2 Cellana LLC Business Overview
  28. 8.5.3 Cellana LLC Health and Medical Microalgae Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Cellana LLC Health and Medical Microalgae Product Portfolio
  30. 8.5.5 Cellana LLC Recent Developments
  31. 8.6 Fuji Chemical Industries Co., Ltd.
  32. 8.6.1 Fuji Chemical Industries Co., Ltd. Company Information
  33. 8.6.2 Fuji Chemical Industries Co., Ltd. Business Overview
  34. 8.6.3 Fuji Chemical Industries Co., Ltd. Health and Medical Microalgae Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Fuji Chemical Industries Co., Ltd. Health and Medical Microalgae Product Portfolio
  36. 8.6.5 Fuji Chemical Industries Co., Ltd. Recent Developments
  37. 8.7 Yunnan Green-A-Bio-engineering Co Ltd
  38. 8.7.1 Yunnan Green-A-Bio-engineering Co Ltd Company Information
  39. 8.7.2 Yunnan Green-A-Bio-engineering Co Ltd Business Overview
  40. 8.7.3 Yunnan Green-A-Bio-engineering Co Ltd Health and Medical Microalgae Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Yunnan Green-A-Bio-engineering Co Ltd Health and Medical Microalgae Product Portfolio
  42. 8.7.5 Yunnan Green-A-Bio-engineering Co Ltd Recent Developments
  43. 8.8 Cyanotech Corporation
  44. 8.8.1 Cyanotech Corporation Company Information
  45. 8.8.2 Cyanotech Corporation Business Overview
  46. 8.8.3 Cyanotech Corporation Health and Medical Microalgae Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Cyanotech Corporation Health and Medical Microalgae Product Portfolio
  48. 8.8.5 Cyanotech Corporation Recent Developments
  49. 8.9 BASF SE
  50. 8.9.1 BASF SE Company Information
  51. 8.9.2 BASF SE Business Overview
  52. 8.9.3 BASF SE Health and Medical Microalgae Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 BASF SE Health and Medical Microalgae Product Portfolio
  54. 8.9.5 BASF SE Recent Developments
  55. 8.10 Parry Nutraceuticals
  56. 8.10.1 Parry Nutraceuticals Company Information
  57. 8.10.2 Parry Nutraceuticals Business Overview
  58. 8.10.3 Parry Nutraceuticals Health and Medical Microalgae Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Parry Nutraceuticals Health and Medical Microalgae Product Portfolio
  60. 8.10.5 Parry Nutraceuticals Recent Developments
  61. 8.11 Beijing Gingko Group
  62. 8.11.1 Beijing Gingko Group Company Information
  63. 8.11.2 Beijing Gingko Group Business Overview
  64. 8.11.3 Beijing Gingko Group Health and Medical Microalgae Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Beijing Gingko Group Health and Medical Microalgae Product Portfolio
  66. 8.11.5 Beijing Gingko Group Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Health and Medical Microalgae Value Chain Analysis
  2. 9.1.1 Health and Medical Microalgae Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Health and Medical Microalgae Sales Mode & Process
  6. 9.2 Health and Medical Microalgae Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Health and Medical Microalgae Distributors
  9. 9.2.3 Health and Medical Microalgae Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst